AI summary · may contain errors
Hypofractionated FLASH-RT (3×10 Gy at 5.5×10 Gy/s) and conventional RT (3×10 Gy at 0.1 Gy/s) both produce long-lasting anti-tumor effects in orthotopic UW228-MB mice.
- Open access
Moving in bioRxiv, Cell Reports Medicine, Clinical Cancer Research, European Respiratory Journal, Journal of Clinical Oncology, Nature Biomedical Engineering and Neuro-Oncology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Hypofractionated FLASH-RT (3×10 Gy at 5.5×10 Gy/s) and conventional RT (3×10 Gy at 0.1 Gy/s) both produce long-lasting anti-tumor effects in orthotopic UW228-MB mice.
AI summary · may contain errors
Simultaneous irradiation on the FLASH-SARRP achieves ~80 Gy/s in a homogeneous field, but tube synchronization shows a 10 ms average delay that creates temporal dose-rate heterogeneity.
AI summary · may contain errors
AP/LC CXCR4 engineered hepatocyte-based micronanorobots deplete intratumoral lactate and, with radiotherapy, sustain DNA damage in radioresistant colorectal and metastatic cervical cancer models.
AI summary · may contain errors
Hypofractionated proton beam therapy (HART) for localized unresectable hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) yields median overall survival of 29.2 months and 20.8 months, respectively.
Journals this month
Topics moving, week to 17 Nov 2026
By field